Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »
Read More
Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now
Every fall, a tight-knit group of investors gathers for a friendly, but fiercely competitive, stock picking challenge. It’s hosted by Paul Tudor Jones, the legendary hedge fund manager. But it isn’t just for a good cause. The top picks from the event, backed by the likes of Bill Ackman and Stan Druckenmiller, would’ve returned 7x your money in just six months.
» Read more about: Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now »
Read More
Is This Beaten-Down AI Powerhouse a Once-in-a-Decade Buying Opportunity?
Buying the dip can feel like a savvy move, but there’s a fine line between a bargain and a “falling knife.” The trick is knowing which is which.
When a company leads its industry, is riding powerful megatrends, and trades at a rare discount, buying the dip might not just be smart, it might be a steal.
» Read more about: Is This Beaten-Down AI Powerhouse a Once-in-a-Decade Buying Opportunity? »
Read More
Is Target Stock a Hidden Gem for Patient Value Investors?
Target (NYSE: TGT) hasn’t had the best run lately. In fact, shares have slid 29.9% so far this year, a sharp contrast to the broader market, with the S&P 500 flat on the year. It’s a tough pill to swallow, especially when you consider Target was already on the back foot coming into 2025.
But here’s the twist,
» Read more about: Is Target Stock a Hidden Gem for Patient Value Investors? »
Read More
Buffett Would Love This Moat, Freeport’s Hidden Growth Engine
In the short run, tariff headlines can turn Mr. Market into a nervous wreck. In the long run, owners do fine by owning scarce, low-cost assets run by rational people. Freeport-McMoRan fits that bill.
U.S. copper prices sold off after Washington excluded refined copper from its new 50% tariffs and instead targeted semi-finished products like wire,
» Read more about: Buffett Would Love This Moat, Freeport’s Hidden Growth Engine »
Read MoreThe Burst
Why the Swoosh Might Be Turning the Corner Fast
Analysts had written off Nike heading into its latest earnings report. The previous quarter was a mess, sales fell 10%, inventories piled up, and the brand that once defined performance and style looked a little out of step with both.
Yet this quarter, Nike did something investors didn’t expect by starting to look like Nike again.
» Read more about: Why the Swoosh Might Be Turning the Corner Fast »
Read MoreThe Ivy
Why This Billionaire Is Buying Google In Spades
In the second quarter, Bill Ackman’s Pershing Square Capital added another 900,000+ shares of Alphabet Class A (NASDAQ: GOOGL).
Combined with its Class C (NASDAQ: GOOG) shares, Alphabet now makes up about 21% of Pershing Square’s portfolio, one of the fund’s biggest bets.
So what makes Alphabet such a perfect Ackman stock,
» Read more about: Why This Billionaire Is Buying Google In Spades »
Read MoreThe Daily
Bitcoin ATMs enable cryptocurrency scams, federal prosecutor alleges
Diane Reynolds said she was caught off guard when someone contacted the Maryland retiree online and said access to her computer had been blocked for safety reasons.
“There was a voice message that was coming on with this that said, ‘Don’t turn your computer on, don’t turn your computer off,’” she told CBS News.
» Read more about: Bitcoin ATMs enable cryptocurrency scams, federal prosecutor alleges »